Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Hepion Pharmaceuticals, Inc. | a2220317zs-1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
ContraVir
Pharmaceuticals, Inc.
New York, New York
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated August 8, 2013, relating to the consolidated financial statements of ContraVir Pharmaceuticals, Inc., which is contained in that Prospectus. Our report on the financial statements contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
We also consent to the reference to us under the caption "Experts" in the Prospectus.
BDO
USA, LLP
New York, New York
June 2, 2014